1. A multicentre, randomised, double blind, placebo controlled phase II study of subcutaneous interferon beta-1a in the treatment of patients with active rheumatoid arthritis. Issue 1 (8th July 2004) Authors: van Holten, J; Pavelka, K; Vencovsky, J; Stahl, H; Rozman, B; Genovese, M; Kivitz, A J; Alvaro, J; Nuki, G; Furst, D E; Herrero-Beaumont, G; McInnes, I B; Musikic, P; Tak, P P Journal: Annals of the rheumatic diseases Issue: Volume 64:Issue 1(2005) Page Start: 64 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗